These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 8910570)
1. The effect of individual amino acids on ApoB100 and Lp(a) secretion by HepG2 cells. Cianflone K; Zhang Z; Vu H; Kohen-Avramoglu R; Kalant D; Sniderman AD J Biol Chem; 1996 Nov; 271(46):29136-45. PubMed ID: 8910570 [TBL] [Abstract][Full Text] [Related]
2. Characterization and modulation of LP(a) in human hepatoma HEPG2 cells. Vu H; Cianflone K; Zhang Z; Kalant D; Sniderman AD Biochim Biophys Acta; 1997 Nov; 1349(2):97-108. PubMed ID: 9421183 [TBL] [Abstract][Full Text] [Related]
3. The role of amino acids in ApoB100 synthesis and catabolism in human HepG2 cells. Zhang Z; Sniderman AD; Kalant D; Vu H; Monge JC; Tao Y; Cianflone K J Biol Chem; 1993 Dec; 268(36):26920-6. PubMed ID: 8262926 [TBL] [Abstract][Full Text] [Related]
4. ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of ApoB. Wilcox LJ; Barrett PH; Newton RS; Huff MW Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):939-49. PubMed ID: 10195921 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of apolipoprotein B secretion by taurocholate is controlled by the N-terminal end of the protein in rat hepatoma McArdle-RH7777 cells. Elzinga BM; Baller JF; Mensenkamp AR; Yao Z; Agellon LB; Kuipers F; Verkade HJ Biochim Biophys Acta; 2003 Dec; 1635(2-3):93-103. PubMed ID: 14729072 [TBL] [Abstract][Full Text] [Related]
6. Exogenous VLDL stimulates apolipoprotein B secretion from HepG2 cells by both pre- and post-translational mechanisms. Wu X; Sakata N; Dixon J; Ginsberg HN J Lipid Res; 1994 Jul; 35(7):1200-10. PubMed ID: 7964181 [TBL] [Abstract][Full Text] [Related]
7. Carboxyl-terminal truncation impairs lipid recruitment by apolipoprotein B100 but does not affect secretion of the truncated apolipoprotein B-containing lipoproteins. McLeod RS; Zhao Y; Selby SL; Westerlund J; Yao Z J Biol Chem; 1994 Jan; 269(4):2852-62. PubMed ID: 8300620 [TBL] [Abstract][Full Text] [Related]
8. The late addition of core lipids to nascent apolipoprotein B100, resulting in the assembly and secretion of triglyceride-rich lipoproteins, is independent of both microsomal triglyceride transfer protein activity and new triglyceride synthesis. Pan M; Liang Js JS; Fisher EA; Ginsberg HN J Biol Chem; 2002 Feb; 277(6):4413-21. PubMed ID: 11704664 [TBL] [Abstract][Full Text] [Related]
9. An analysis of the interaction between mouse apolipoprotein B100 and apolipoprotein(a). Cheesman EJ; Sharp RJ; Zlot CH; Liu CY; Taylor S; Marcovina SM; Young SG; McCormick SP J Biol Chem; 2000 Sep; 275(36):28195-200. PubMed ID: 10837476 [TBL] [Abstract][Full Text] [Related]
10. Role of cholesterol ester mass in regulation of secretion of ApoB100 lipoprotein particles by hamster hepatocytes and effects of statins on that relationship. Zhang Z; Cianflone K; Sniderman AD Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):743-52. PubMed ID: 10073982 [TBL] [Abstract][Full Text] [Related]
11. Demonstration of biphasic effects of docosahexaenoic acid on apolipoprotein B secretion in HepG2 cells. Wu X; Shang A; Jiang H; Ginsberg HN Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3347-55. PubMed ID: 9409332 [TBL] [Abstract][Full Text] [Related]
12. The effect of low density lipoproteins, cholesterol, and 25-hydroxycholesterol on apolipoprotein B gene expression in HepG2 cells. Dashti N J Biol Chem; 1992 Apr; 267(10):7160-9. PubMed ID: 1313035 [TBL] [Abstract][Full Text] [Related]
13. MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly. Tsai J; Qiu W; Kohen-Avramoglu R; Adeli K Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):211-8. PubMed ID: 17038630 [TBL] [Abstract][Full Text] [Related]
14. Oleate-mediated stimulation of apolipoprotein B secretion from rat hepatoma cells. A function of the ability of apolipoprotein B to direct lipoprotein assembly and escape presecretory degradation. White AL; Graham DL; LeGros J; Pease RJ; Scott J J Biol Chem; 1992 Aug; 267(22):15657-64. PubMed ID: 1639804 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of the endoplasmic reticulum 60 protein ER-60 downregulates apoB100 secretion by inducing its intracellular degradation via a nonproteasomal pathway: evidence for an ER-60-mediated and pCMB-sensitive intracellular degradative pathway. Qiu W; Kohen-Avramoglu R; Rashid-Kolvear F; Au CS; Chong TM; Lewis GF; Trinh DK; Austin RC; Urade R; Adeli K Biochemistry; 2004 Apr; 43(16):4819-31. PubMed ID: 15096051 [TBL] [Abstract][Full Text] [Related]
16. Expression of human apolipoprotein B90 in transgenic mice. Demonstration that apolipoprotein B90 lacks the structural requirements to form lipoprotein. McCormick SP; Linton MF; Hobbs HH; Taylor S; Curtiss LK; Young SG J Biol Chem; 1994 Sep; 269(39):24284-9. PubMed ID: 7929084 [TBL] [Abstract][Full Text] [Related]
17. Level of apolipoprotein B mRNA has an important effect of the synthesis and secretion of apolipoprotein B-containing lipoproteins. Studies on transfected hepatoma cell lines expressing recombinant human apolipoprotein B. Selby SL; Yao Z Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1900-10. PubMed ID: 7583570 [TBL] [Abstract][Full Text] [Related]
18. Cotranslational inhibition of apoB-100 synthesis by cyclosporin A in the human hepatoma cell line HepG2. Kaptein A; de Wit EC; Princen HM Arterioscler Thromb; 1994 May; 14(5):780-9. PubMed ID: 8172854 [TBL] [Abstract][Full Text] [Related]
19. Oleate stimulates the formation of triglyceride-rich particles containing apoB100-apo(a) in long-term primary cultures of human hepatocytes. Edelstein C; Davidson NO; Scanu AM Chem Phys Lipids; 1994 Jan; 67-68():135-43. PubMed ID: 8187207 [TBL] [Abstract][Full Text] [Related]
20. Intracellular mechanisms mediating the inhibition of apoB-containing lipoprotein synthesis and secretion in HepG2 cells by avasimibe (CI-1011), a novel acyl-coenzyme A: cholesterol acyltransferase (ACAT) inhibitor. Taghibiglou C; Van Iderstine SC; Kulinski A; Rudy D; Adeli K Biochem Pharmacol; 2002 Feb; 63(3):349-60. PubMed ID: 11853686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]